Opinion: Quality Tuberculosis care starts with people

Opinion: Quality Tuberculosis care starts with people

The world is seeing tuberculosis (TB) deaths increase for the first time in over a decade. To turn things around and to put an end to TB being a leading infectious disease killer globally, we need to make sure the voices of people affected by TB are at the core of developing person-centered, quality TB care, free from stigma and discrimination, argue a group of TB experts and activists.

Read More

Opinion: WHO numbers underscore urgent need for stronger leadership and ambitious TB recovery plan

Opinion: WHO numbers underscore urgent need for stronger leadership and ambitious TB recovery plan

According to new estimates from the World Health Organization around 61 000 people died of TB in South Africa in 2020, an increase of around 5% over 2019. That works out to over 1 100 TB deaths in the country every week. We urgently need a transparent TB recovery plan and we need both President Cyril Ramaphosa and Health Minister Joe Phaahla to invest real political capital in the implementation of the plan, the authors argue.

Read More

In-depth: Landmark moment as AI beats humans in reading X-rays for TB

In-depth: Landmark moment as AI beats humans in reading X-rays for TB

“The results are in: artificial intelligence (AI) outperforms humans at reading chest X-rays for signs of tuberculosis,” proclaimed a recent newsletter of the Stop TB Partnership. Tiyese Jeranji spoke to a variety of experts about the landmark study behind this proclamation and asked what AI-aided X-ray interpretation may mean for countries like South Africa with high TB burdens.

Read More

Important TB drug as effective at lower dose, study finds

Important TB drug as effective at lower dose, study finds

The treatment of drug-resistant forms of tuberculosis has been transformed over the last decade with treatment becoming more effective, safer, and treatment duration in many cases dropping to under a year. Even so, treatment can still come with serious side effects and for some, it can still last over a year and a half. In a finding that may help further reduce side effects, new research has found that the dosage of a key drug can be lowered without compromising how well it works. Tiyese Jeranji and Marcus Low report.

Read More

Opinion: Could community health workers be the answer to reducing Tuberculosis stigma?

Opinion: Could community health workers be the answer to reducing Tuberculosis stigma?

Tuberculosis stigma thrives when TB is spoken about in hushed whispers, or behind closed doors. The truth is anyone who breathes can get TB as it is an airborne disease like COVID-19. We can all reduce the harmful effect of TB stigma in our communities by taking part in activities that break down false and unfair attitudes towards people with TB. Community health workers are leading the way and deserve more support, write authors from TB Proof.

Read More

After setbacks, rollout of new TB prevention pills to start in six districts

After setbacks, rollout of new TB prevention pills to start in six districts

After various delays and setbacks, a new, less toxic, short-course tuberculosis preventive therapy called 3HP is finally being launched in six districts in South Africa. Tiyese Jeranji reports.

Read More

SA piloting mobile X-rays to improve TB detection

SA piloting mobile X-rays to improve TB detection

South Africa’s first National Tuberculosis Prevalence Survey found that many people without TB symptoms nevertheless have TB disease that can be detected using chest X-rays. Accordingly, new mobile X-ray screening programmes are being piloted in a number of provinces. Tiyese Jeranji reports.

Read More

In-depth: SA at cutting edge of TB vaccine research

In-depth: SA at cutting edge of TB vaccine research

It is a hundred years since the BCG vaccine, the only registered vaccine proven to offer some protection against tuberculosis (TB), was first used in people. Now researchers in South Africa are at the forefront of clinical trials testing experimental new TB vaccines. Adele Baleta reports.

Read More

400 people in SA with highly drug-resistant TB to get new three-drug regimen

400 people in SA with highly drug-resistant TB to get new three-drug regimen

Treating highly drug-resistant forms of tuberculosis can take anything from nine to 24 months and patients have to contend with various unpleasant, and sometimes dangerous, side effects. A new six-month regimen made up of just three drugs that will be offered to 400 patients in South Africa might offer a better solution for some. Tiyese Jeranji reports.

Read More

In-depth: Getting Gauteng’s HIV and TB response back on track

In-depth: Getting Gauteng’s HIV and TB response back on track

From March to July this year, the Gauteng Department of Health recorded 57 848 TB tests – a decrease of about 30 000 tests compared to the same period last year. The province performed better with HIV testing, although the HIV response has faltered in other areas. Melissa Javan makes sense of the province’s numbers and speaks to activists and community health workers about the impact of lockdown on their services and plans to get things back on track.  

Read More

TB in children: Exciting treatment advances, but better tests badly needed

TB in children: Exciting treatment advances, but better tests badly needed

Children shoulder approximately 12% of the global TB burden, and this proportion is likely higher in high TB burden countries. In South Africa, up to 30 000 children develop TB each year. Tiyese Jeranji spoke to TB expert, Dr Megan Palmer from Brooklyn Chest Hospital about treatment challenges and how to improve TB detection and treatment outcomes in children.

Read More

Eastern Cape government mum on TB plans and numbers

Eastern Cape government mum on TB plans and numbers

Numbers from the National Institute of Communicable Disease and from some provinces show that TB diagnoses have dropped dramatically in 2020 – likely due to COVID-19 and the related lockdown. The Eastern Cape Department of Health has however declined to share information on the TB situation in the province and their catch-up plans. Some activists are concerned about the situation. Luvuyo Mehlwana reports.

Read More